ijms-logo

Journal Browser

Journal Browser

G Protein-Coupled Receptor Signaling and Regulation, 2nd Edition

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: 30 November 2026 | Viewed by 2453

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA
Interests: arrestin proteins; structure-function; protein engineering; GPCR signaling; GPCR trafficking; receptor regulation; cell proliferation; apoptosis; MAP kinases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

G protein-coupled receptors (GPCRs) are the largest family of proteins in animals, with more than 800 distinct subtypes in humans. GPCRs are targeted by a larger percentage of clinically used drugs than any other protein family. All GPCRs have seven α-helical transmembrane domains (that is why they are also called seven transmembrane domain receptors, or 7TMRs) and, upon stimulation, change their conformation. Different GPCRs respond to light, odorants, pheromones, taste molecules, hormones, neurotransmitters, extracellular calcium, and many other stimuli. Most GPCRs couple to the G proteins (hence the name). GPCRs serve as guanyl nucleotide exchange factors (GEFs) for heterotrimeric G proteins, facilitating the release of bound GDP and the binding of GTP abundant in the cytoplasm. GTP-liganded G protein α-subunit dissociates from the βγ-subunit, whereupon both subunits interact with various effectors, regulating their activity. Active GPCR during its lifetime activates several G protein molecules, thereby amplifying the signal. Most effectors are enzymes or ion channels, ensuring additional signal amplification. G protein α-subunits self-inactivate via intrinsic GTPase activity. RGS (Regulators of G protein signaling) proteins facilitate this self-inactivation. Many GPCRs are regulated by the phosphorylation by GPCR kinases (GRKs) that specifically target active receptors. Active phosphorylated GPCRs bind arrestin proteins with high affinity. Arrestin binding precludes GPCR coupling to G proteins, often mediates the recruitment of the receptor to the coated pits for internalization, and initiates arrestin-mediated signaling.

Research articles, review articles, and communications on every aspect of GPCR activation and regulation, as well as on proteins participating in GPCR signal transduction, are invited for submission.

Prof. Dr. Vsevolod V. Gurevich
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • GPCRs
  • signaling
  • trafficking
  • G proteins
  • arrestins
  • RGS proteins
  • GRKs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 9224 KB  
Review
Bitter Chinese Herbal Medicine Exerts Pharmacological Effects via TAS2Rs: A Systematic Review from Natural Ligands to Therapeutic Potential
by Lian Li, Ruitong Dong, Shibu Feng, Yan Huang, Xin Li, Hanyun Que, Huan Li, Peng Wang, Leu-Kim Fey, Yi Zhang, Zhaotong Cong and Sanyin Zhang
Int. J. Mol. Sci. 2026, 27(7), 3073; https://doi.org/10.3390/ijms27073073 - 27 Mar 2026
Viewed by 1076
Abstract
Bitter compounds may function not only as taste substances but also as important active constituents mediating therapeutic effects. Their recognition is primarily mediated by bitter taste receptors (TAS2Rs), which exert pharmacological effects, such as regulating glucose metabolism, anti-inflammatory properties, and immune modulation, aligning [...] Read more.
Bitter compounds may function not only as taste substances but also as important active constituents mediating therapeutic effects. Their recognition is primarily mediated by bitter taste receptors (TAS2Rs), which exert pharmacological effects, such as regulating glucose metabolism, anti-inflammatory properties, and immune modulation, aligning closely with the therapeutic effects of bitter Chinese herbal medicine (BCHM). Contemporary pharmacological research has increasingly underscored the therapeutic potential of bitter traditional Chinese medicine (TCM), particularly through their bioactive constituents in the prevention and treatment of diverse pathological conditions. Here, we systematically review the diversity of bitter compounds from TCM and features of TAS2Rs, including their tissue distribution, physiological functions, structural characteristics, signal transduction mechanisms, and single-nucleotide polymorphisms. While numerous bitter phytochemicals have been characterized as agonists of TAS2Rs, the precise physiological functions and underlying molecular mechanisms mediated by TAS2R activation remain incompletely elucidated. This knowledge gap is largely attributable to several methodological and biological challenges, including the widespread tissue distribution of TAS2Rs, the complexity of their downstream signaling cascades, and the structural and functional heterogeneity of bitter compounds. This review outlines theoretical foundations, future perspectives and challenges for the drug development of TAS2R from BCHM. Full article
(This article belongs to the Special Issue G Protein-Coupled Receptor Signaling and Regulation, 2nd Edition)
Show Figures

Figure 1

21 pages, 921 KB  
Review
The Mechanism of G Protein-Coupled Receptor Regulation of Ferroptosis in Hepatic Ischemia–Reperfusion Injury
by Die Hu, Lei Sun, Mei Su and Xuekun Xing
Int. J. Mol. Sci. 2026, 27(6), 2866; https://doi.org/10.3390/ijms27062866 - 22 Mar 2026
Viewed by 878
Abstract
Hepatic ischemia–reperfusion injury (HIRI) is a significant clinical challenge in the field of liver surgery and transplantation, and its pathological mechanisms are complex. In recent years, ferroptosis, a novel form of iron-dependent programmed cell death, plays a central role in this injury process. [...] Read more.
Hepatic ischemia–reperfusion injury (HIRI) is a significant clinical challenge in the field of liver surgery and transplantation, and its pathological mechanisms are complex. In recent years, ferroptosis, a novel form of iron-dependent programmed cell death, plays a central role in this injury process. G protein-coupled receptors (GPCRs), as the largest family of membrane receptors in the body, regulate cellular stress and death through extensive signaling networks. This review elucidates the specific molecular mechanisms by which GPCRs regulate ferroptosis in HIRI by affecting key pathways such as lipid peroxidation, iron metabolism homeostasis, and antioxidant defense. It further explores potential therapeutic strategies targeting specific GPCRs to modulate ferroptosis, thereby alleviating liver injury and improving postoperative outcomes, to provide new insights and a theoretical basis for clinical translation. Full article
(This article belongs to the Special Issue G Protein-Coupled Receptor Signaling and Regulation, 2nd Edition)
Show Figures

Graphical abstract

Back to TopTop